[HTML][HTML] Interaction between the epidermal growth factor receptor (EGFR) and the vascular endothelial growth factor (VEGF) pathways: a rational approach for multi …
F Ciardiello, T Troiani, R Bianco, M Orditura… - Annals of …, 2006 - Elsevier
Over the last decade, the concept of targeted biological therapy for the treatment of cancer
has emerged. However, a better understanding of these targets and their role in tumor cells …
has emerged. However, a better understanding of these targets and their role in tumor cells …
Effective and specific gene silencing of epidermal growth factor receptors mediated by conjugated oxaborole and galactose-based polymers
D Diaz-Dussan, Y Nakagawa, YY Peng… - ACS Macro …, 2017 - ACS Publications
Oxaborole-based polymers are stimuli-responsive materials that can reversibly interact with
diols at pH values higher than their p K a. The strong binding of the oxaborole with cis …
diols at pH values higher than their p K a. The strong binding of the oxaborole with cis …
Recent advances in the development of novel anti‐cancer drugs targeting cancer stem/progenitor cells
M Mimeault, SK Batra - Drug Development Research, 2008 - Wiley Online Library
Recent advances in basic and clinical oncology have led to the identification and
characterization of several deregulated gene products involved in cancer progression to …
characterization of several deregulated gene products involved in cancer progression to …
Analysis of signaling pathways in 90 cancer cell lines by protein lysate array
K Natarajan Mendes, D Nicorici… - Journal of proteome …, 2007 - ACS Publications
Multiple signal transduction pathways play a crucial role in cancer development,
progression, and response to different therapies. An important issue is whether common …
progression, and response to different therapies. An important issue is whether common …
Receptor-mediated DNA-targeted photoimmunotherapy
TC Karagiannis, PN Lobachevsky, BKY Leung… - Cancer research, 2006 - AACR
We show the efficacy of a therapeutic strategy that combines the potency of a DNA-binding
photosensitizer, UVA Sens, with the tumor-targeting potential of receptor-mediated …
photosensitizer, UVA Sens, with the tumor-targeting potential of receptor-mediated …
Breaking B‐cell tolerance and CTL tolerance in three OVA‐transgenic mouse strains expressing different levels of OVA
L Steinaa, PB Rasmussen, A Gautam… - Scandinavian journal …, 2008 - Wiley Online Library
It is of major importance to overcome the immunological tolerance in attempts to generate
efficient tumour vaccines. Here, we describe induction of autoantibodies and self‐reactive …
efficient tumour vaccines. Here, we describe induction of autoantibodies and self‐reactive …
Egfr/nedd9/tgf-beta interactome and methods of use thereof for the identification of agents having efficacy in the treatment of hyperproliferative disorders
I Astsaturov, EA Golemis, IG Serebriiskii… - US Patent App. 12 …, 2010 - Google Patents
2010-06-02 Assigned to FOX CHASE CANCER CENTER reassignment FOX CHASE
CANCER CENTER ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR …
CANCER CENTER ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR …
[HTML][HTML] Changing the course of oncogenesis: The development of tyrosine kinase inhibitors
JC Lacal - European Journal of Cancer Supplements, 2006 - Elsevier
Over the past 30 years a huge amount of information has been gathered about tumour
biology and the carcinogenic process. It is known that cancer develops as a result of a …
biology and the carcinogenic process. It is known that cancer develops as a result of a …
Production and Verification of Anti-Tumor Activity of Monoclonal Anti-EGFR-Recombinant PE38 Immunotoxin in A431 Tumor Cells
Background: Tumor growth and progression depend largely on the activity of cell membrane
receptors like epidermal growth factor receptor (EGFR). This receptor plays a significant role …
receptors like epidermal growth factor receptor (EGFR). This receptor plays a significant role …
Egfr/nedd9/tgf-beta interactome and methods of use thereof for the identification of agents having efficacy in the treatment of hyperproliferative disorders
I Astsaturov, EA Golemis, IG Serebriiskii… - US Patent App. 13 …, 2013 - Google Patents
ZRKFYGHZFMAOKI-QMGMOQQFSA-N Tgfbeta Chemical compound C ([C@ H](NC (=
O)[C@ H](C (C) C) NC (= O) CNC (= O)[C@ H](CCC (O)= O) NC (= O)[C@ H](CCCNC (N) …
O)[C@ H](C (C) C) NC (= O) CNC (= O)[C@ H](CCC (O)= O) NC (= O)[C@ H](CCCNC (N) …